Article
The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation.
Molecular autism - 1 Jan 2017
Charman Tony, Loth Eva, Tillmann Julian, Crawley Daisy, Wooldridge Caroline, Goyard David, Ahmad Jumana, Auyeung Bonnie, Ambrosino Sara, Banaschewski Tobias, Baron-Cohen Simon, Baumeister Sarah, Beckmann Christian, Bölte Sven, Bourgeron Thomas, Bours Carsten, Brammer Michael, Brandeis Daniel, Brogna Claudia, de Bruijn Yvette, Chakrabarti Bhismadev, Cornelissen Ineke, Acqua Flavio Dell', Dumas Guillaume, Durston Sarah, Ecker Christine, Faulkner Jessica, Frouin Vincent, Garcés Pilar, Ham Lindsay, Hayward Hannah, Hipp Joerg, Holt Rosemary J, Isaksson Johan, Johnson Mark H, Jones Emily J H, Kundu Prantik, Lai Meng-Chuan, D'ardhuy Xavier Liogier, Lombardo Michael V, Lythgoe David J, Mandl René, Mason Luke, Meyer-Lindenberg Andreas, Moessnang Carolin, Mueller Nico, O'Dwyer Laurence, Oldehinkel Marianne, Oranje Bob, Pandina Gahan, Persico Antonio M, Ruggeri Barbara, Ruigrok Amber N V, Sabet Jessica, Sacco Roberto, Cáceres Antonia San Jóse, Simonoff Emily, Toro Roberto, Tost Heike, Waldman Jack, Williams Steve C R, Zwiers Marcel P, Spooren Will, Murphy Declan G M, Buitelaar Jan K
Abstract excerpt
BACKGROUND: The EU-AIMS Longitudinal European Autism Project (LEAP) is to date the largest multi-centre, multi-disciplinary observational study on biomarkers for autism spectrum disorder (ASD). The current paper describes the clinical characteristics of the LEAP cohort and examines age, sex and IQ differences in ASD core symptoms and common co-occurring psychiatric symptoms. A companion paper describes the...
Read the complete abstract on PubMed